Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

genetic counseling midterm > Cancer GC > Flashcards

Cancer GC Flashcards

(50 cards)

Start Studying
1
Q

Prevalence of BRCA1/2

A

1/400

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

BRCA 1 contributes…

A

20-40% to HBOC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

BRCA 2 contributes…

A

10-30% to HBOC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Genomic mechanisms associated with BRCA 1 and 2

A 
Maintains genomic integrity
Damage repair
regulated gene expression
ubiquinates proteins
chromatin remodeling
cell cycle control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is BRCA inherited

A

Autosomal dominant
reduced penetrance
transmission through males and females
maternal and paternal history are important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Features of HBOC

A
  • Multiple family members affected across several generations
  • BC under the age of 50
  • Epithelial ovarian cancer at any age
  • Male breast cancer
  • Multiple primary cancer diagnoses (esp bilateral BC)
  • Triple negative breast cancer under the age of 60 (estrogen/progesterone/her2neu)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Other cancer risk

A 
Male BC
prostate cancer
pancreatic cancer
melanoma
colon
endometrial
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Risk for second breast cancer

A

up to 50% lifetime risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ER/PR+

A

Selective estrogen receptor modulators: tamoxifan if pre-menopausal and Raloxifene if post-menopausal (can also use aromatase inhibitors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Her-2/neu+

A

herceptin antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

triple negative

A

ER/PR and her-2/neu receptor negative

very common in women with BRCA 1 mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

BRCA 1

A
  • likely to be triple negative
  • higher risk for ovarian cancer (44%)
  • male breast cancer
  • slight risk for melanoma, pancreatic cancer and prostate cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

BRCA 2

A
  • likely to be ER/PR+
  • risk for ovarian cancer (27%)
  • high risk for melanoma, pancreatic cancer and prostate cancer
  • risk for male breast cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Testing for BRCA 1 and 2

A

comprehensive= 85% detection, looks at 5 rearrangements
BART= additional rearrangements, only increases detection 3%
Single site is done if mutation is known
3 site is done for the most common AJ mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Claus

A

lifetime cancer risk assessment, if greater than 20% add MRI to the screen

strengths: includes age, mat and pat history, age of affected family members and ovarian cancer
limits: maximum of 2 primary or secondary relatives, cannot be male, only for unaffected probands, must have a family history, and cannot include other risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Gail

A

5 year cancer risk assessment for tamoxifen or raloxifene prescription ( >1.6% risk)
Strengths: incorporates information other than the family history
Limits: can only include 2 1st degree relatives, no ages, no paternal, no ovarian cancer, only calculates risk for women >35 yo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Myriad

A

risk table
Strength: easy to use, readily available
limit: biased population, not exact (age or number of relatives), doesnt incorporate anything other than breast and ovarian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

BRCAPro

A

Bayes
Limits: depends on current mutation frequency and penetrance data, assumes all affecteds are due to BRCA 1 and 2, does not use prostate or pancreatic cancer, computationally intensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Couch and TC

A

Assess risk for unaffected to develop BC not for ovarian, captures pedigree and personal medical history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cleveland Clinic for PTEN

A

risk calculation based on a questionare, score decides if patient should get testing for PTEN, a score of 3% or higher indicates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lynch syndrome

Study These Flashcards
A

Right sided, multiple tumors with MSI histology and immunohistochemical results indicating.

22
Q

Amsterdam I

Study These Flashcards
A

3 family members with colon cancer (where 1 is a first degree relative of the other 2)
2 generations affected
1 colon cancer diagnosed prior to age 50
Rule out FAP

23
Q

Amsterdam II

Study These Flashcards
A

Same as Amsterdam I, but the three family members can have any of the associated lynch cancers; endometrial, ovarian, gastric, small bowel, urothelial, CNS, pancreatic

24
Q

Lynch genes

Study These Flashcards
A

MSH2: MSH6 only binds to this protein, if MSH2 is mutated will not show on IHC (MSH2 can also be hypermethylated, studies can confirm, but are rare)
MSH6
PMS2
MLH1: PMS1 only binds here
EPCAM: will show loss if MSH2 is missing.

25
NCCN for Lynch
colonoscopy every 1-2 years starting 2-5 years before earliest onset BSO and hysterectomy after reproduction no strict screening for other associated cancers
26
FCCTX
Familial colon cancer without MMR, MSI or IHC, but meets amsterdam I
27
Guidlines for FCCTX
colonoscopy every 5 years starting 5-10 years prior to earliest diagnosis
28
FAP
classic or attenuated, due to mutations in the APC gene or the MYH gene. very high cancer risk. 100-70%
29
NCCN Guidelines for FAP
test, monitor, colonoscopy, colectomy and polypectomy, monitor with endoscopy every 6-12 months
30
Li Fraumini
Rare AD caused by mutation in tp53, 50% risk of cancer by age 35. Sarcoma, brain, breast, adrenocortical carcinoma, leukemia.
31
Cowden
AD, PTEN, breast, thyroid, endometrial, renal cell, melanoma, colorectal
32
Peutz-Jegher
AD, STK11, colon, breast, pancreas, stomach, ovaries and others.
33
high risk genes
BRCA1/2, CDH1, EPCAM, MLH1, MSH2, MSH6, PMS2, PTEN, TP53, STK11, APC
34
Moderate risk genes
ATM, PALB2, CHEK2
35
Newer genes
BRIP1, BMPR1A, NBN, BARD1, RAD51C, RAD51D, CDKN
36
Stages of grief
``` Denial Guilt Depression Anger Acceptance ```
37
indications for referral
suspected malformation syndrome (multiple, dysmorphic appearance, unusual birth marks or a single defect, idiopathic developmental, growth or cognitive delay), second opinion relatives have a known diagnosis
38
goals of the evaluation
``` establish a diagnosis provide accurate individualized counseling (include recurrence risk) estimate prognosis provide treatment formulate a care plan obtain appropriate tests initiate referrals as needed offer support (always) ```
39
defense mechanisms
``` denial intellectualization regression repression sublimation reaction formation ```
40
coping mechanisms
``` problem solving support seeking talking doing withdrawal ```
41
4 tenets of GC
the relationship is integral patient autonomy is supported patients are resilient patient emotions make a difference
42
Self-psychology
the self is dependent on maintaining a relational context and having experiences that fortify the self
43
Self in relation
deemphasizes concepts of individuation and separation for ego formation (encourages self empathy)
44
Family systems theory
we are all part of a family system and our responses to information will be influenced by the system at play in our family of origin as well as the cultural context in which we were raised. therefore individuals are best understood through family dynamics
45
approaches to family therapy
1. strategic 2. structural 3. multigenerational
46
family systems illness model (genetic)
considers the unique challenges that genomic conditions present especially in at risk and asymptomatic individuals
47
systematically based psychotheraputic model
includes the genogram | links individuals to interactional and intergenerational issues in the scope of a genetics issue
48
early intervention services
0-3 developmental delay premature/low birth weight/ postnatal illness or surgery at risk groups receive: physical, cognitive, social/emotional, communication and self help services must have family participation includes: family teaching model, transdisciplinary model, transition planning
49
Part B
3-21 education based -vision, hearing, gross and fine motor, speech and language, social/emotional. diagnosis vs developmental delay reevaluated every 5 years, includes transition Families participate in goad identification
50
Preschool services
3- age of beginner - must have significant delay - physical or mental disability - and need special education and related services - uses and IEP for school and aid services - wraparound available for children W/ DSM 5 diagnosis

genetic counseling midterm (1 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions